State Street’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
|
|||||
|
2025
Q1 | $907K | Sell |
|
|||||
|
2024
Q4 | $2.79M | Sell |
|
|||||
|
2024
Q3 | $5.49M | Buy |
|
|||||
|
2024
Q2 | $4.46M | Buy |
|
|||||
|
2024
Q1 | $6.75M | Buy |
|
|||||
|
2023
Q4 | $3.18M | Buy |
|
|||||
|
2023
Q3 | $2.64M | Buy |
|
|||||
|
2023
Q2 | $3.12M | Buy |
|
|||||
|
2023
Q1 | $562K | Buy |
|
|||||
|
2022
Q4 | $80.2K | Hold |
|
|||||
|
2022
Q3 | $205K | Buy |
|
|||||
|
2022
Q2 | $234K | Sell |
|
|||||
|
2022
Q1 | $773K | Buy |
|
|||||
|
2021
Q4 | $1.28M | Sell |
|
|||||
|
2021
Q3 | $2.18M | Buy |
|
|||||
|
2021
Q2 | $2.9M | Buy |
|
|||||
|
2021
Q1 | $2.62M | Buy |
|
|||||
|
2020
Q4 | $2.43M | Buy |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|